Steven Dahl
Sourced from institutional research profiles (UAMS TRI or ARA).
Role not yet determined
Also affiliated: Arkansas Children's Hospital (2023–2026); Children's Mercy Hospital (2019–2021); University of Missouri–Kansas City (2021)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Steven Dahl's research focuses on infectious diseases and their impact on pediatric populations. He has investigated antibiotic prescribing practices in outpatient pediatrics, including a multicenter collaborative study benchmarking these practices. His work also includes examining the clinical presentations and serotype distribution of invasive pneumococcal disease in children, comparing those with and without underlying risk factors.
Dahl has also studied rare and severe pediatric conditions, such as Ehrlichia-induced hemophagocytic lymphohistiocytosis in a kidney transplant recipient and fatal tick-borne diseases presenting with HLH-like syndromes. His publications include a report on a fatal case of Naegleria fowleri meningoencephalitis associated with a splash pad. He has collaborated with researchers at the University of Arkansas for Medical Sciences on several shared publications.
Metrics
- h-index: 3
- Publications: 15
- Citations: 34
Selected Publications
-
P-447. Differences in Invasive Pneumococcal Disease Clinical Presentations and Serotype Distribution among Children with and without Underlying Risk Factors (2026)
-
Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023 (2025)
-
P-646. Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals (2025)
-
Identifying Disparities in Outpatient Antibiotic Prescribing for Urinary Tract Infections (2024)
-
Evaluating the Impact of Order Set Implementation in Prescribing Practices for Pediatric Urinary Tract Infections Between a Non-academic and an Academic Children’s Hospital in the Inpatient General Pediatric Population (2024)
-
Assessment of Broad-Spectrum Antibiotic Usage Following Initiation of Handshake Stewardship in a Pediatric Intensive Care Unit: A Quality Improvement Initiative (2024)
-
Feasibility and Prevalence of Early Antibiotic De-Escalation in Patients with Viral Encephalitis (2024)
-
828: FATAL TICK-BORNE DISEASE IN A VERY YOUNG INFANT: AN UNUSUAL DRIVER OF HLH-LIKE SYNDROME (2023)
Collaboration Network
Top Collaborators
- Evaluating the Impact of Order Set Implementation in Prescribing Practices for Pediatric Urinary Tract Infections Between a Non-academic and an Academic Children’s Hospital in the Inpatient General Pediatric Population
- Feasibility and Prevalence of Early Antibiotic De-Escalation in Patients with Viral Encephalitis
- Assessment of Broad-Spectrum Antibiotic Usage Following Initiation of Handshake Stewardship in a Pediatric Intensive Care Unit: A Quality Improvement Initiative
- Identifying Disparities in Outpatient Antibiotic Prescribing for Urinary Tract Infections
- Evaluating the Impact of Order Set Implementation in Prescribing Practices for Pediatric Urinary Tract Infections Between a Non-academic and an Academic Children’s Hospital in the Inpatient General Pediatric Population
- Feasibility and Prevalence of Early Antibiotic De-Escalation in Patients with Viral Encephalitis
- Assessment of Broad-Spectrum Antibiotic Usage Following Initiation of Handshake Stewardship in a Pediatric Intensive Care Unit: A Quality Improvement Initiative
- Identifying Disparities in Outpatient Antibiotic Prescribing for Urinary Tract Infections
- Evaluating the Impact of Order Set Implementation in Prescribing Practices for Pediatric Urinary Tract Infections Between a Non-academic and an Academic Children’s Hospital in the Inpatient General Pediatric Population
- Feasibility and Prevalence of Early Antibiotic De-Escalation in Patients with Viral Encephalitis
- Assessment of Broad-Spectrum Antibiotic Usage Following Initiation of Handshake Stewardship in a Pediatric Intensive Care Unit: A Quality Improvement Initiative
- Identifying Disparities in Outpatient Antibiotic Prescribing for Urinary Tract Infections
- Evaluating the Impact of Order Set Implementation in Prescribing Practices for Pediatric Urinary Tract Infections Between a Non-academic and an Academic Children’s Hospital in the Inpatient General Pediatric Population
- Feasibility and Prevalence of Early Antibiotic De-Escalation in Patients with Viral Encephalitis
- Assessment of Broad-Spectrum Antibiotic Usage Following Initiation of Handshake Stewardship in a Pediatric Intensive Care Unit: A Quality Improvement Initiative
- Identifying Disparities in Outpatient Antibiotic Prescribing for Urinary Tract Infections
- Evaluating the Impact of Order Set Implementation in Prescribing Practices for Pediatric Urinary Tract Infections Between a Non-academic and an Academic Children’s Hospital in the Inpatient General Pediatric Population
- Feasibility and Prevalence of Early Antibiotic De-Escalation in Patients with Viral Encephalitis
- Assessment of Broad-Spectrum Antibiotic Usage Following Initiation of Handshake Stewardship in a Pediatric Intensive Care Unit: A Quality Improvement Initiative
- Identifying Disparities in Outpatient Antibiotic Prescribing for Urinary Tract Infections
- P-646. Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals
- Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023
- P-447. Differences in Invasive Pneumococcal Disease Clinical Presentations and Serotype Distribution among Children with and without Underlying Risk Factors
- P-646. Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals
- Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023
- P-447. Differences in Invasive Pneumococcal Disease Clinical Presentations and Serotype Distribution among Children with and without Underlying Risk Factors
- P-646. Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals
- Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023
- P-447. Differences in Invasive Pneumococcal Disease Clinical Presentations and Serotype Distribution among Children with and without Underlying Risk Factors
- P-646. Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals
- Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023
- P-447. Differences in Invasive Pneumococcal Disease Clinical Presentations and Serotype Distribution among Children with and without Underlying Risk Factors
- P-646. Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals
- Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023
- P-447. Differences in Invasive Pneumococcal Disease Clinical Presentations and Serotype Distribution among Children with and without Underlying Risk Factors
- P-646. Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals
- Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023
- P-646. Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals
- Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023
- P-646. Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals
- Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023
- P-646. Culture Positive Pneumococcal Pneumonia Requiring Hospital Admission from 2017-2022 at Eight US Children’s Hospitals
- Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023
- Invasive Pneumococcal Disease at Eight Children’s Hospitals in the United States, 2018–2023
- P-447. Differences in Invasive Pneumococcal Disease Clinical Presentations and Serotype Distribution among Children with and without Underlying Risk Factors
Similar Researchers
Based on overlapping research topics